Jianya Zhou, Xiaochen Zhang, Chengxiang Guo, Hui Wang, Yuping Sun, Xinjun Liang, Qian Chu, Lin Wu, Caicun Zhou, Jian Fang, Yueyin Pan, Jiuwei Cui, Zhangzhou Huang, Yu Chen, Chengzhi Zhou, Xiaoqing Liu, Yu Yang, Ning Li, Tongmei Zhang, Hui Zhou. "First-in-class PD-1/IL-2
                    <sup>α-bias</sup>
                    bispecific antibody IBI363 (TAK-928) in patients (pts) with advanced immunotherapy-resistant non–small cell lung cancer (NSCLC): Updated results from a phase I study.." Journal of Clinical Oncology (2026). https://doi.org/10.1200/jco.2026.44.16_suppl.2618